ab52771 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab52771 は 20 報の論文で使用されています。

  • Li P  et al. Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma. J Cancer Res Clin Oncol 142:1765-73 (2016). WB . PubMed: 27325246
  • Ye L  et al. Decreased Yes-Associated Protein-1 (YAP1) Expression in Pediatric Hearts with Ventricular Septal Defects. PLoS One 10:e0139712 (2015). PubMed: 26426694
  • Stein C  et al. YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers. PLoS Genet 11:e1005465 (2015). PubMed: 26295846
  • Ma B  et al. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Nat Cell Biol 17:95-103 (2015). PubMed: 25438054
  • Whiteman EL  et al. Crumbs3 is essential for proper epithelial development and viability. Mol Cell Biol 34:43-56 (2014). Mouse . PubMed: 24164893
  • Dixit D  et al. Chaetocin-induced ROS-mediated apoptosis involves ATM-YAP1 axis and JNK-dependent inhibition of glucose metabolism. Cell Death Dis 5:e1212 (2014). WB ; Human . PubMed: 24810048
  • Wang J  et al. Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer. Hepatology N/A:N/A (2013). Human . PubMed: 23532963
  • Michaloglou C  et al. The tyrosine phosphatase PTPN14 is a negative regulator of YAP activity. PLoS One 8:e61916 (2013). ICC/IF . PubMed: 23613971
  • Xiao W  et al. Mutual interaction between YAP and c-Myc is critical for carcinogenesis in liver cancer. Biochem Biophys Res Commun 439:167-72 (2013). WB, IHC ; Human . PubMed: 23994632
  • Sun G & Irvine KD Ajuba family proteins link JNK to Hippo signaling. Sci Signal 6:ra81 (2013). PubMed: 24023255
  • Li S  et al. Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep 4:1116-30 (2013). WB ; Human . PubMed: 24055055
  • Wang J  et al. Impaired phosphorylation and ubiquitination by p70 S6 kinase (p70S6K) and Smad ubiquitination regulatory factor 1 (Smurf1) promote tribbles homolog 2 (TRIB2) stability and carcinogenic property in liver cancer. J Biol Chem 288:33667-81 (2013). WB ; Human . PubMed: 24089522
  • Yang S  et al. CDK1 phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation. Cancer Res 73:6722-33 (2013). IP . PubMed: 24101154
  • Tanaka I  et al. LIM-domain protein AJUBA suppresses malignant mesothelioma cell proliferation via Hippo signaling cascade. Oncogene N/A:N/A (2013). PubMed: 24336325
  • Li L  et al. MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer. FEBS Lett 587:3921-7 (2013). IHC ; Human . PubMed: 24211253
  • Fujii M  et al. TGF-ß synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J Exp Med 209:479-94 (2012). WB ; Human . PubMed: 22329991
  • Sheen-Chen SM  et al. Yes-associated protein is not an independent prognostic marker in breast cancer. Anticancer Res 32:3321-5 (2012). PubMed: 22843909
  • Murakami H  et al. LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res 71:873-83 (2011). WB, ICC/IF, IHC-P ; Human . PubMed: 21245096
  • Kang W  et al. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. Clin Cancer Res 17:2130-9 (2011). IHC . PubMed: 21346147
  • Cai J  et al. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 24:2383-8 (2010). PubMed: 21041407